Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae

OBJECTIVES: Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this, however evidence regarding risk of hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, Anais, Liauw, Winston, Kennedy, Helen, Alzahrani, Nayef A., Morris, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166178/
https://www.ncbi.nlm.nih.gov/pubmed/35812006
http://dx.doi.org/10.1515/pp-2022-0107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166178/
https://www.ncbi.nlm.nih.gov/pubmed/35812006
http://dx.doi.org/10.1515/pp-2022-0107

Ejemplares similares